DAFTAR PUSTAKA
Andres, C., Jose, E., Martin, H., Alicia, L., dan Hiart, M., 2007. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model. Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy, 60: 605–612. Antariksa, B., Djajalaksana, S., Pradjnaparamita, Riyadi, J., Yunus, F., Suradi, dkk., 2011. Diagnosis Dan Penatalaksanaan, Perhimpunan Dokter Paru Indonesia. Perhimpunan Dokter Paru Indonesia, pp 31-63. Agmy, G., Mohamed, S., Gad, Y., Farghally, E., Mohammedin, H., dan Rashed, H., 2013. Bacterial Profile, Antibiotic Sensitivity and Resistance of Lower Respiratory Tract Infections in Upper Egypt. Mediterranean Journal of Hematology and Infectious Diseases, 5:(1) Babar, A, 2003. Penyakit Paru Obstruktif Kronik Pedoman Penatalaksanaan Global Terbaru. Dalam: Pertemuan Ilmiah Nasional I (PB PAPDI 2003). Pusat Informasi dan Penerbitan Bagian Ilmu Penyakit Dalam FK UI, Jakarta. Baratawidjaja, K.G. dan Rengganis, I., 2012. Imunologi Dasar, 10th ed. Badan Penerbit FKUI, Jakarta. Bisht, R., Katiyar, A., Singh, R., Mittal, P. Antibiotic resistance-A global issue of concern. Asian journal of pharmaceutical and clinical research. Volume 2. Issue 2. Boudet, S.V., and Williams, D. M, 2003. Penyakit Paru Obstruktif Kronis (PPOK), Viewed 11 Desember 2012, http://www.Goldcopd.com. Brunton, L., Lazo, J., dan Parker, K., 2005. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, Eleventh Edition. McGraw Hill Professional. Brusse-Keizer, M.G.J., Grotenhuis, A.J., Kerstjens, H.A.M., Telgen, M.C., van der Palen, J., Hendrix, M.G.R., dkk., 2009. Relation of sputum colour to bacterial load in acute exacerbations of COPD. Respiratory medicine, 103: 601–606. Burgess, D.S., dan Abate, B.J., 2005, Antimicrobial Regimen Selection dalam Pharmacotherapy_A Phathophisiologic Approacch Sixth edition. Editor, Dipiro. JT., McGraw-hill Medical Companies Inc. Celli, B.R., Agusti, A., Anzueto, A., Berg, B., Buist, A.., Chavannes, N., dkk., 2004. Standards for the diagnosis and treatment of patients with copd. European Respiratory Journal, 23: 932–946. Chin, T.L., Mayer, R., Fletcher, W., Guideline for the Empirical Treatment of Infections in Adults, Royal United Hospital Bath NHS trust. Diakses pada tanggal3 November 2013, http://www.ruh.nhs.uk/about/policies/document.pdf.
74
Dewan, N., Rafique, S., dan Kanwar, B., 2000. Acute exacerbation of COPD. Factors associated with poor treatment outcome. Chest, 117: 662–671. DiPiro, J., Talbert, R.L., Yee, G.C., Matzke, G.R., dan Wells, B.G., 2008. Pharmacotherapy and Pharmacotherapy Casebook 7th Ed. Value Pack. McGraw-Hill Companies,Incorporated. pp 495-514. Dorland, W.A.N. dan Mahode, A.A., 2012. Kamus saku kedokteran Dorland. Elsevier (Singapore), hal 117. Drago, L., Mattina, R., Legnani, D., Romano, C.L., Vianello, E., Ricci, C., dkk., 2011. Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone. International Journal of Immunopathology and Pharmacology, 24: 1027–1035. Fanning, M., McKean, M., Seymour, K., Pillans, P., dan Scott, I., 2014. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Internal Medicine Journal, 44: 903–910. Fein, A., 2000. Management of acute exacerbations in chronic obstruvtive pulmonary disease. Current Opinion in Pulmonary Medicine, 6: 122–126. Frank, U. dan Tacconelli, E., 2012. The Daschner Guide to In-Hospital Antibiotic Therapy: European Standards. Springer Science & Business Media. Global Initiative for Chronic Obstructive, 2010. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2010, diakses 11 january 2012, http://www.goldcopd.org Global Initiative for Chronic Obstructive, 2013. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2013, diakses 05 Desember 2014, http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf Güder, G. dan Rutten, F.H., 2014. Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More than Coincidence. Current Heart Failure Reports, 11: 337–346. Gunawan, S.G., Setiabudy, R., Nafrialdi, dan Elysabeth (Eds.), 2012. Farmakologi Dan Terapi, 5th ed. Badan Penerbit FKUI, Jakarta. Gyssens, I.C., 2006. Audits for Monitoring the Quality of Antimicrobial Prescriptions, dalam: Gould, I.M., Meer, J.W.M. van der (Eds.), Antibiotic Policies: Theory and Practice. Springer, hal. 197–226. Ikawati, Z., 2006, Farmakoterapi Penyakit Sistem Pernafasan, Laboratorium farmakologi dan farmasi klinik bagian farmakologi dan farmasi klinik. Fak. Farmasi UGM. Yogyakarta. Joshi, Joshi, Dr Desai, Dr Gothi, Dr Desai, Dr Gothi, dkk., 2012. COPD Exacerbations: Clinical Management Options. Indian Journal of Clinical Medicine, 1.
75
Juwono, R. dan Prayitno, A., 2003, Terapi Antibiotika, dalam Aslam, M., Tan, C.K., Prayitno, A. (Eds), Farmasi Klinis, Menuju Pengobatan Rasional dan Penghargaan Pilihan Pasien, PT. Elex Media Komputindo, Jakarta. Katzung, B.G., Masters, S., dan Trevor, A., 2011. Basic and Clinical Pharmacology 12/E. McGraw Hill Professional. Keatings, V.M., Jatakanon, A., Worsdell, Y.M., dan Barnes, P.J., 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. American Journal of Respiratory and Critical Care Medicine, 155: 542–548. Kementerian Kesehatan. 2008, Peraturan Menteri Kesehatan Republik Indonesia, Nomor 1022/Menkes/SK/XI/2008, tentang Pedoman Pengendalian Penyakit Paru Obstruktif Kronik, Jakarta, Kementerian Kesehatan Republik Indonesia. Kementerian Kesehatan. 2011, Peraturan Menteri Kesehatan Republik Indonesia, Nomor 2406/Menkes/Per/XII/2011, tentang Pedoman Umum Penggunaan Antibiotik, Jakarta, Kementerian Kesehatan Republik Indonesia. Kessler, R., Faller, M., Fourgaut, G., Mennecier, B., dan Weitzenblum, E., 1999. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 159: 158–164. Lestari, Asih P. 2003, 'Evaluasi Penggunaan Antibiotika Pada Pasien Pneumonia di RSUD DR. Sardjito Yogyakarta', Tesis, Msc, Fakultas Farmasi, universitas Gadjah Mada, Yogyakarta. Llor, C., Moragas, A., Hernández, S., Bayona, C., dan Miravitlles, M., 2012. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 186: 716–723. Lloyd, A., Holman, A., dan Evers, T., 2008. A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. Current Medical Research and Opinion, 24: 1279–1284. MacIntyre, N. dan Huang, Y., 2008. Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 5: 530–535. Martantya, R., Nasrul, E., dan Basyar, M., 2014. Gambaran Hitung Jenis Leukosit pada Pasien Penyakit Paru Obstruktif Kronik yang Dirawat di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 3: (2). Melissa, H., Hunter, M.., Dana, E., dan King, M.., 2001. COPD: Management of Acute Exacerbations and Chronic Stable Disease. American Family Physician, 64: 603–612,621–622. Miravitlles, M., Moragas, A., Hernández, S., Bayona, C., dan Llor, C., 2013. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest, 144: 1571–1577.
76
Miyazaki, M., Nakamura, H., Chubachi, S., Sasaki, M., Haraguchi, M., Yoshida, S., dkk., 2014. Analysis of comorbid factors that increase the COPD assessment test scores. Respiratory Research, 15: 13. National Health Performance Authority, 2001, nhpa Length of Stay in Public Hospitals in 2011-2012, 16: 13-20, Viewed 4 September 2014, http://nhpa.go.au. Navarro, R.P., 2009. Managed Care Pharmacy Practice. Jones & Bartlett Publishers. Nelwan, R.H.H., 2002, Pemakaian Antimikroba secara Rasional di Klinik, dalam Noer, S. dkk (eds): Buku ajar Penyakit Dalam, Jilid I, pp. 537-541, Balai Penerbit FKUI, Jakarta. Niewoehner, D.E., Lokhnygina, Y., Rice, K., Kuschner, W.G., Sharafkhaneh, A., Sarosi, G.A., dkk., 2007. Risk indexes for exacerbations and hospitalizations due to COPD. Chest, 131: 20–28. Pulver, L.K., Wai, A., Maxwell, D.J., Robertson, M.B., dan Riddell, S., 2011. Implementation and evaluation of a multisite drug usage evaluation program across Australian hospitals - a quality improvement initiative. BMC Health Services Research, 11: 206. Rahayu, Y. 2014, 'Evaluasi Rasionalitas Penggunaan Antibiotik terhadap Outcome Pada Pasien Anak Penderita Pneumonia studi Kasus Di RS. Dr.R.Soetrasno Rembang, Tesis, Msc, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta. Rahmatika, A., 2010. Karakteristik Penderita Penyakit Paru Obstruktif Kronik yang di Rawat Inap di RSUD Aceh Tamiang Tahun 2007-2008. Universitas Sumatera Utara. Available from: http://repository.usu.ac.id [accessed 7 Desember 2013]. Rybak MJ,. Aeschlimann JR., 2005, Laboratory test to direct antimicrobial pharmacotherapy dalam Pharmacotherapy_A Pathophysiologic Approach Sixth edition. Editor, Dipiro.JT., McGraw-hill Medical Companies Inc. Rilawati, FD. 2011, 'Evaluasi Penggunaan Antibiotik Pada Pasien Gangguan Ginjal di Rumah Sakit PKU Muhamadiyah Yogyakarta', Tesis, Msc, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta. Riyanto. B.S, Hisyam. B., 2006., Obstruksi Saluran Pernafasan. In: Sudoyo, ed. Buku Ajar Ilmu Penyakit Dalam. Jilid ke-2. Edisi ke-4. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia. Robert. A., 2007., Chronic Obstructive Pulmonary Disease. In: Fisman AP, Elias JA, Fishman JA, Grippi MA, Senior RM., Fishman's Pulmonary Disease and disorder. 4th ed. Philadelphia. MCGraw-Hill. Sethi, S., Maloney, J., Grove, L., Wrona, C., dan Berensen, C., 2006. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 173: 991–998.
77
Stephen,. J., 2005. Pneumonia, Bacterial. eMedicine-Pneumonia, Bacterial, htm. 2005. http://www.emedicine.com/pneumonia. Stiell, I.G., Clement, C.M., Aaron, S.D., Rowe, B.H., Perry, J.J., Brison, R.J., dkk., 2014. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. Canadian Medical Association Journal, cmaj.130968. Stockley, R.A., Rennard, S.I., Rabe, K., dan Celli, B., 2008. Chronic Obstructive Pulmonary Disease: A Practical Guide to Management. John Wiley & Sons. Sub-Committee, V.D.U.A.C.A.G. dan Foundation, V.M.P., 1996. Antibiotic Guidelines. Victorian Medical Postgraduate Foundation. Sulivan, S., Scott, D., dan Todd, A., 2000. The Economic Borden of COPD, dalam: 1. Syamsudin dan Keban, S., 2013. Buku Ajar Farmakoterapi Gangguan Saluran Pernapasan. Salemba Medika,40: 34-41 Tierney, L.M., McPhee, S.J., and Papadakis, Maxine., 2002.Current Medical Diagnosis & Treatment, 45th Edition, McGraw-Hill. Tjay, T.H., Rahardja, K., 2002. Obat-obat Penting: Khasiat, Penggunaan dan Efekefek Sampingnya. Edisi VI. Jakarta: PT. Elex Media Komputindo. Tripathi, K.D., 2003. Antimicrobial drugs: general consideration. Essentials of Medical Pharmacology. Fifth edition. Jaypee Brothers Medical Publishers. Vandenesch, F., Naimi, T., Enright, M.C., Lina, G., Nimmo, G.R., Heffernan, H., dkk., 2003. Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence. Emerging Infectious Diseases, 9: 978–984. Victorian Drug Usage Evaluation Group, 2008, Standards of Practice for Drug Usage Evaluation in Australian Hospitals May 2004, Australia, 34 (3): pp. 220-223. Wedzicha, J.A. dan Donaldson, G.C., 2003. Exacerbations of chronic obstructive pulmonary disease. Respiratory care, 48: 1204–1213; discussion 1213–1215. Weigel, L.M., 2003. Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus. Science, 302: 1569–1571. WHO, Drug and Therapeutic Committes, A Practical Guide Departement of Essential Drug and Medicines Policy Geneva, Swittzerland, 2003. Widodo, D., 2003, Beta Laktam, Antibiotik Time Dependent Killing: Seftriakson sebagai salah satu Pengecualian, Simposium 4th Jakarta Antimikrobial Update 2003 (Divisi Infeksi dan Penyakit Tropik FKUI). Jakarta. Widodo dan Pohan, 2004, Bunga Rampai Penyakit Infeksi, Divisi Penyakit Tropik dan Infeksi, Departemen Ilmu Penyakit Dalam, FKUI, Jakarta. Wilson, R., Sethi, S., Anzueto, A., dan Miravitlles, M., 2013. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease. The Journal of infection, 67: 497–515. Woodhead, M., 2005. antibiotic for copd. European Respiratory Journal, 26: 1138– 1180.
78
World Health Organization. 2002, WHO Smoking Statistics. Available from: di akses pada tanggal 04 Desember 2011, http://www.wpro.who.int/research. Yamaya, M., Azuma, A., Takizawa, H., Kadota, J., Tamaoki, J., dan Kudoh, S., 2012. Macrolide effects on the prevention of COPD exacerbations. European Respiratory Journal, 40: 485–494.
79
